13 February 2020 - Foreign governments accused of taking unfair advantage of U.S. company research.
Foreign governments are taking unfair advantage of American drug company research and U.S. consumers by artificially suppressing drug prices abroad, a new study from the White House said.
The findings suggest drug pricing could become another source of friction between the U.S. and trading partners, similar to China’s appropriation of U.S. intellectual property and European “digital taxes” on big American technology companies.